Evidence map›Paper›PMID 38250253›Full record

ArticleStat2022

Controlling costs: Feature selection on a budget.

Guo Yu, Daniela Witten, Jacob Bien

Abstract read
In one paragraph

Article in Stat, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Guo YuDepartment of Statistics and Applied Probability, University of California Santa Barbara, Santa Barbara, California, USA.ORCID 0000-0002-3480-6921
Daniela WittenDepartment of Statistics and Biostatistics, University of Washington, Seattle, Washington, USA.
Jacob BienDepartment of Data Sciences and Operations, Marshall School of Business, University of Southern California, Los Angeles, California, USA.

Funding

High-dimensional unsupervised learning, with applications to genomicsDP5OD009145 · OD · UNIVERSITY OF WASHINGTON · PI WITTEN, DANIELA · 2011 to 2015
$1.8M
A Modeling Framework for Multi-View Data, with Applications to the Pioneer 100 Study and Protein Interaction NetworksR01GM123993 · NIGMS · UNIVERSITY OF WASHINGTON · PI BIEN, JACOB, WITTEN, DANIELA · 2017 to 2020
$1.3M
NIGMS NIH HHS R01 GM123993NIH HHS DP5 OD009145
6 · The paper itself

Abstract

The traditional framework for feature selection treats all features as costing the same amount. However, in reality, a scientist often has considerable discretion regarding which variables to measure, and the decision involves a tradeoff between model accuracy and cost (where cost can refer to money, time, difficulty or intrusiveness). In particular, unnecessarily including an expensive feature in a model is worse than unnecessarily including a cheap feature. We propose a procedure, which we call cheap knockoffs, for performing feature selection in a cost-conscious manner. The key idea behind our method is to force higher cost features to compete with more knockoffs than cheaper features. We derive an upper bound on the weighted false discovery proportion associated with this procedure, which corresponds to the fraction of the feature cost that is wasted on unimportant features. We prove that this bound holds simultaneously with high probability over a path of selected variable sets of increasing size. A user may thus select a set of features based, for example, on the overall budget, while knowing that no more than a particular fraction of feature cost is wasted. We investigate, through simulation and a biomedical application, the practical importance of incorporating cost considerations into the feature selection process.

Indexed as

feature costfeature selectionmultiple knockoffsweighted false discovery proportion

Identifiers

PMID38250253
PMCPMC10798788

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.